Literature DB >> 21297068

Asthma and chronic obstructive pulmonary disease: common genes, common environments?

Dirkje S Postma1, Marjan Kerkhof, H Marike Boezen, Gerard H Koppelman.   

Abstract

Asthma and chronic obstructive pulmonary disease (COPD) show similarities and substantial differences. The Dutch hypothesis stipulated that asthma and COPD have common genetic and environmental risk factors (allergens, infections, smoking), which ultimately lead to clinical disease depending on the timing and type of environmental exposures (Postma and Boezen, Chest 2004;126:96S-104S). Thus, a particular group of shared genetic factors may lead to asthma when combined with specific environmental factors that are met at a certain stage in life, whereas combination with other environmental factors, or similar environmental factors at a different stage in life, will lead toward COPD. Multiple genes have been found for asthma and COPD. In addition to genes unique to these diseases, some shared genetic risk factors exist. Moreover, there are both common host risk factors and environmental risk factors for asthma and COPD. Here we put forward, based on the data available, that genes that affect lung development in utero and lung growth in early childhood in interaction with environmental detrimental stimuli, such as smoking and air pollution, are contributing to asthma in childhood and the ultimate development of COPD. Additional genes and environmental factors then drive specific immunological mechanisms underlying asthma, and others may contribute to the ultimate development of specific subtypes of COPD (i.e., airway disease with mucous hypersecretion, small airway disease, and emphysema). The genetic predisposition to the derailment of certain pathways may further help to define subgroups of asthma and COPD. In the end this may lead to stratification of patients by their genetic make-up and open new therapeutic prospects.

Entities:  

Mesh:

Year:  2011        PMID: 21297068     DOI: 10.1164/rccm.201011-1796PP

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  31 in total

Review 1.  Genetics of allergic diseases.

Authors:  Romina A Ortiz; Kathleen C Barnes
Journal:  Immunol Allergy Clin North Am       Date:  2014-11-21       Impact factor: 3.479

Review 2.  Future of environmental research in the age of epigenomics and exposomics.

Authors:  Nina Holland
Journal:  Rev Environ Health       Date:  2017-03-01       Impact factor: 3.458

Review 3.  Airway and lung remodelling in chronic pulmonary obstructive disease: a role for muscarinic receptor antagonists?

Authors:  Michael Roth
Journal:  Drugs       Date:  2015-01       Impact factor: 9.546

4.  Common genes underlying asthma and COPD? Genome-wide analysis on the Dutch hypothesis.

Authors:  Joanna Smolonska; Gerard H Koppelman; Cisca Wijmenga; Judith M Vonk; Pieter Zanen; Marcel Bruinenberg; Ivan Curjuric; Medea Imboden; Gian-Andri Thun; Lude Franke; Nicole M Probst-Hensch; Peter Nürnberg; Roland A Riemersma; Constant P van Schayck; Daan W Loth; Guy G Brusselle; Bruno H Stricker; Albert Hofman; André G Uitterlinden; Lies Lahousse; Stephanie J London; Laura R Loehr; Ani Manichaikul; R Graham Barr; Kathleen M Donohue; Stephen S Rich; Peter Pare; Yohan Bossé; Ke Hao; Maarten van den Berge; Harry J M Groen; Jan-Willem J Lammers; Willem Mali; H Marike Boezen; Dirkje S Postma
Journal:  Eur Respir J       Date:  2014-07-03       Impact factor: 16.671

Review 5.  Immune Dysfunction in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Tariq A Bhat; Louis Panzica; Suresh Gopi Kalathil; Yasmin Thanavala
Journal:  Ann Am Thorac Soc       Date:  2015-11

6.  The clinical and genetic features of COPD-asthma overlap syndrome.

Authors:  Megan Hardin; Michael Cho; Merry-Lynn McDonald; Terri Beaty; Joe Ramsdell; Surya Bhatt; Edwin J R van Beek; Barry J Make; James D Crapo; Edwin K Silverman; Craig P Hersh
Journal:  Eur Respir J       Date:  2014-05-29       Impact factor: 16.671

7.  Association between occupational exposure and the clinical characteristics of COPD.

Authors:  Denis Caillaud; Franck Lemoigne; Philippe Carré; Roger Escamilla; Pascal Chanez; Pierre-Régis Burgel; Isabelle Court-Fortune; Gilles Jebrak; Christophe Pinet; Thierry Perez; Graziella Brinchault; Jean-Louis Paillasseur; Nicolas Roche
Journal:  BMC Public Health       Date:  2012-04-26       Impact factor: 3.295

8.  Validation of novel wheeze phenotypes using longitudinal airway function and atopic sensitization data in the first 6 years of life: evidence from the Southampton Women's survey.

Authors:  Samuel A Collins; Katharine C Pike; Hazel M Inskip; Keith M Godfrey; Graham Roberts; John W Holloway; Jane S A Lucas
Journal:  Pediatr Pulmonol       Date:  2013-02-08

9.  Stage-dependent association of BDNF and TGF-β1 with lung function in stable COPD.

Authors:  Paul Stoll; Urs Wuertemberger; Kai Bratke; Christiana Zingler; J Christian Virchow; Marek Lommatzsch
Journal:  Respir Res       Date:  2012-12-17

10.  The search for common pathways underlying asthma and COPD.

Authors:  Yoshiko Kaneko; Yohei Yatagai; Hideyasu Yamada; Hiroki Iijima; Hironori Masuko; Tohru Sakamoto; Nobuyuki Hizawa
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2013-01-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.